Local Controlled Release of Polyphenol Conjugated with Gelatin Facilitates Bone Formation

• Main Authors: Yoshitomo Honda, Tomonari Tanaka, Tomoko Tokuda, Takahiro Kashiwagi, Koji Kaida, Ayato Hieda, Yasuyuki Umezaki, Yoshiya Hashimoto, Koichi Imai, Naoyuki Matsumoto, Shunsuke Baba, Kimishige Shimizutani
• Format: Article
• Language: English
• Published: MDPI AG 2015-06-01
• Series: International Journal of Molecular Sciences
• Subjects: catechin; EGCG; bone formation; gelatin; mesenchymal stem cells
• Online Access: http://www.mdpi.com/1422-0067/16/6/14143

Catechins are extensively used in health care treatments. Nevertheless, there is scarce information about the feasibility of local administration with polyphenols for bone regeneration therapy, possibly due to lack of effective delivery systems. Here we demonstrated that the epigallocatechin-3-gallate-conjugated gelatin (EGCG/Gel) prepared by an aqueous chemical synthesis using 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-morpholinium chloride (DMT-MM) gradually disintegrated with time and facilitated bone formation in a critical size defect of a mouse calvaria. Conjugation of EGCG with the Gel generated cross-linking between the two molecules, thereby leading to a retardation of the degradation of the EGCG/Gel and to a delayed release of EGCG. The prepared EGCG/Gels represented significant osteogenic capability compared with that of the uncross-linked Gel and the cross-linked Gel with uncombined-EGCG. In vitro experiments disclosed that the EGCG/Gel induced osteoblastogenesis of a mouse mesenchymal stem cell line (D1 cells) within 14 days. Using fluorescently-labeled EGCG/Gel, we found that the fraction of EGCG/Gel adsorbed onto the cell membrane of the D1 cells possibly via a Gel-cell interaction. The interaction might confer the long-term effects of EGCG on the cells, resulting in a potent osteogenic capability of the EGCG/Gel in vivo. These results should provide insight into local controlled release of polyphenols for bone therapy.